BR112012019295A2 - polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo. - Google Patents

polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo.

Info

Publication number
BR112012019295A2
BR112012019295A2 BR112012019295-7A BR112012019295A BR112012019295A2 BR 112012019295 A2 BR112012019295 A2 BR 112012019295A2 BR 112012019295 A BR112012019295 A BR 112012019295A BR 112012019295 A2 BR112012019295 A2 BR 112012019295A2
Authority
BR
Brazil
Prior art keywords
polynucleotide
tase
roux
homolog
protein
Prior art date
Application number
BR112012019295-7A
Other languages
English (en)
Japanese (ja)
Inventor
Ochiai Misa
Original Assignee
Suntory Holdings Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Limited filed Critical Suntory Holdings Limited
Publication of BR112012019295A2 publication Critical patent/BR112012019295A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
    • C12Y602/01—Acid-Thiol Ligases (6.2.1)
    • C12Y602/01001—Acetate-CoA ligase (6.2.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
    • C12Y602/01—Acid-Thiol Ligases (6.2.1)
    • C12Y602/01003—Long-chain-fatty-acid-CoA ligase (6.2.1.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Obesity (AREA)

Abstract

polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo, a presente invenção se refere a uma proteina homólogo da acil-coa sistetase derivada de micro-organismos do gênero mortierella, um polinucleotídeo que codifica a proteína, entre outros. a invenção fornece polinucleotídeos que compreendem o gene de uma proteína homóloga da acil-coa sintese a partir de, por exemplo, mortierella alpina, vetores de expressão que compreendem esses polinucleotídeos e seus transformadores, produtos método para produção de lipídios ou ácidos graxos utilizando os transformantes, um método para produção de lipídios ou ácidos graxos utilizando os transformantes, produtos alimentícios contendo os lipídios ou ácidos graxos produzidos pelo método, entre outros.
BR112012019295-7A 2010-02-01 2011-02-01 polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo. BR112012019295A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010019967 2010-02-01
JP2010019967 2010-02-01
PCT/JP2011/052035 WO2011093509A1 (ja) 2010-02-01 2011-02-01 アシル-CoAシンセターゼホモログをコードするポリヌクレオチド及びその用途

Publications (1)

Publication Number Publication Date
BR112012019295A2 true BR112012019295A2 (pt) 2018-06-12

Family

ID=44319486

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012019295-7A BR112012019295A2 (pt) 2010-02-01 2011-02-01 polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo.

Country Status (11)

Country Link
US (3) US9289007B2 (pt)
EP (3) EP2772538B1 (pt)
JP (3) JP5795267B2 (pt)
KR (3) KR101709384B1 (pt)
CN (3) CN104388439B (pt)
AU (1) AU2011211291B2 (pt)
BR (1) BR112012019295A2 (pt)
CA (3) CA2851105A1 (pt)
DK (3) DK2930236T3 (pt)
RU (1) RU2528248C2 (pt)
WO (1) WO2011093509A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2528248C2 (ru) 2010-02-01 2014-09-10 Сантори Холдингз Лимитед Полинуклеотид, кодирующий гомолог ацил-соа-синтетазы, и его применение
JP2016512021A (ja) 2013-03-08 2016-04-25 アクシオム フーズ インコーポレイテッド 米タンパク質補助食品
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
JP6778207B2 (ja) * 2015-10-30 2020-10-28 サントリーホールディングス株式会社 Ａｏｂｇｌ３ホモログを用いたステビオール配糖体およびステビオールの製造方法
EP3502265B1 (en) * 2016-07-19 2020-12-02 Suntory Holdings Limited Method for producing mogrol or mogrol glycoside
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的***和方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244192A1 (en) 1999-01-14 2007-10-18 Martek Biosciences Corporation Plant seed oils containing polyunsaturated fatty acids
RU2268939C2 (ru) * 1999-06-07 2006-01-27 Басф Плант Сайенс Гмбх ДЕЛЬТА 6-АЦЕТИЛЕНАЗА/ДЕЛЬТА-6-ДЕСАТУРАЗА И ДЕЛЬТА-6-ДЕСАТУРАЗА ИЗ Ceratodon purpureus
DK1181373T3 (da) 1999-06-07 2006-11-27 Basf Plant Science Gmbh Delta-6-acetylenase og delta-6-desaturase ud fra Ceratodon purpureus
JP4231170B2 (ja) 1999-10-26 2009-02-25 サントリー株式会社 酵母の育種方法
US20030037357A1 (en) 2000-07-21 2003-02-20 Washington State University Research Foundation Plant acyl-CoA synthetases
US20040010817A1 (en) 2000-07-21 2004-01-15 Washington State University Research Foundation Plant acyl-CoA synthetases
US7105722B2 (en) 2000-07-21 2006-09-12 Washington State University Plant acyl-CoA synthetases
KR101187081B1 (ko) 2003-08-22 2012-09-27 산토리 홀딩스 가부시키가이샤 지질생산균의 취득방법
JP4481702B2 (ja) 2004-03-31 2010-06-16 サントリーホールディングス株式会社 脂質生産菌の育種方法およびその利用
EP2080769A3 (en) 2004-07-02 2010-12-01 Metanomics GmbH Process for the production of fine chemicals
GB0421937D0 (en) * 2004-10-02 2004-11-03 Univ York Acyl CoA synthetases
MX2007007040A (es) 2004-12-17 2008-10-24 Metanomics Gmbh Proceso para el control de produccion de productos quimicos finos.
KR101506347B1 (ko) 2006-03-15 2015-03-26 디에스엠 아이피 어셋츠 비.브이. 다불포화 지방산을 함유하는 식물 종자 오일
CN101473038B (zh) * 2006-03-15 2014-05-28 Dsmip资产公司 含有多不饱和脂肪酸的植物种子油
US7927845B2 (en) 2006-05-08 2011-04-19 Suntory Holdings Limited Fatty acid synthetase, polynucleotide encoding the same, and uses thereof
CN1969640B (zh) * 2006-12-06 2010-08-25 深圳市儿童医院 酮食液体奶
WO2010115156A2 (en) 2009-04-03 2010-10-07 Synthetic Genomics, Inc. Endophytic fungus and uses therefor
RU2528248C2 (ru) 2010-02-01 2014-09-10 Сантори Холдингз Лимитед Полинуклеотид, кодирующий гомолог ацил-соа-синтетазы, и его применение

Also Published As

Publication number Publication date
JP2016034275A (ja) 2016-03-17
JP2016025859A (ja) 2016-02-12
EP2537927A4 (en) 2013-08-21
JP6150857B2 (ja) 2017-06-21
US9289007B2 (en) 2016-03-22
JP5795267B2 (ja) 2015-10-14
KR20120094135A (ko) 2012-08-23
CN104388439A (zh) 2015-03-04
US9828596B2 (en) 2017-11-28
EP2930236A1 (en) 2015-10-14
KR20170019480A (ko) 2017-02-21
EP2537927A1 (en) 2012-12-26
DK2930236T3 (en) 2018-03-19
KR101758591B1 (ko) 2017-07-14
US20160230166A1 (en) 2016-08-11
WO2011093509A1 (ja) 2011-08-04
CN104388439B (zh) 2018-02-23
EP2772538A1 (en) 2014-09-03
US20120322992A1 (en) 2012-12-20
JPWO2011093509A1 (ja) 2013-06-06
KR101438985B1 (ko) 2014-09-25
EP2537927B1 (en) 2015-09-30
RU2528248C2 (ru) 2014-09-10
EP2930236B1 (en) 2017-12-27
CA2851105A1 (en) 2011-08-04
DK2772538T3 (da) 2016-03-07
CA2907905A1 (en) 2011-08-04
EP2772538B1 (en) 2016-01-13
CN104388438A (zh) 2015-03-04
CN102906259A (zh) 2013-01-30
RU2012137109A (ru) 2014-03-10
US9822354B2 (en) 2017-11-21
CA2787832A1 (en) 2011-08-04
AU2011211291A1 (en) 2012-08-30
CN102906259B (zh) 2014-11-05
AU2011211291B2 (en) 2014-05-15
JP6150856B2 (ja) 2017-06-21
KR20140042939A (ko) 2014-04-07
KR101709384B1 (ko) 2017-02-22
CA2787832C (en) 2016-01-05
DK2537927T3 (en) 2015-11-09
US20160230165A1 (en) 2016-08-11

Similar Documents

Publication Publication Date Title
BR112012019295A2 (pt) polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo.
Sreenikethanam et al. Genetic engineering of microalgae for secondary metabolite production: Recent developments, challenges, and future prospects
MY176018A (en) Composition useful for the treatment of lipid metabolism disorders
CO6351713A2 (es) Composición nutricional para promover desarrollo y crecimiento sanos
MX2015008199A (es) Formulaciones de acido eicosapentaenoico (epa).
BR112015017920A2 (pt) molécula de ácido nucleico codificando uma proteína transportadore de acila (acp)-acila tioesterase variante, cassete de expressão, vetor, tioesterase (te) variante de proteína transportadora de acila-acila (acp), célula hospedeira, produto de óleo, método para produzir uma planta, alga ou microalga, que produz um óleo com um perfil de ácido graxo desejado, e método para produzir um óleo
PE20200448A1 (es) Produccion de acidos grasos poliinsaturados de cadena larga en celulas vegetales
BR112012015410A2 (pt) genes diacilglicerol aciltransferase e uso dos mesmos.
CY1117616T1 (el) Διαδικασια για την απομονωση φωσφολιπιδιου
AR089441A1 (es) Capsulas de gelatina/alginato de liberacion retardada que comprenden acidos grasos omega-3 y metodos y usos de las mismas, metodo de manufactura, composicion farmaceutica
WO2018067849A3 (en) Novel acyltransferases, variant thioesterases, and uses thereof
BR112015015632A2 (pt) acil-acp tioesterase
BR112014013593A8 (pt) retenção de dha durante o processamento de óleo de canola
BR112017028300A2 (pt) composição nutricional, creme de café, métodos para fabricação de caseína micelar e para preparação uma composição nutricional
NZ747847A (en) Lipid compositions
BR112019004623A2 (pt) métodos para preparar ácidos graxos livres e derivados de ácidos graxos a partir de misturas lipídicas de matéria prima ou de matéria prima de sabão
MY181997A (en) Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid
BR112018001164A2 (pt) composto de fórmula geral, composição farmacêutica e método para o tratamento de uma doença cardiovascular
PE20140803A1 (es) Composiciones nutricionales que tienen particulas solidas y metodos para hacer y usar las mismas
WO2014144461A3 (en) Engineered organisms for production of novel lipids
WO2012171001A3 (en) Food products containing beta-glucans and omega-3 fatty acids
BR112014024523A2 (pt) sistema de gordura de panificação
AR098539A1 (es) Producción de ácido grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa pufa traustoquitridio
BR112018012043A2 (pt) processo para a redução da transpiração
TR201908153T4 (tr) Besleyici bileşimler ve bunların kullanımları.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]